Genotyping Assay Market to 2023 – Growing Steady at 22.0% CAGR and Projected to Reach US$ 31.9 Billion

Get This Report with Special Discount | Genotyping Assay Market report provides analysis of top players in all regions with industry size, growth, revenue, cost, sales, technology, market insights, demand, trend, key statistics and industry forecasts to 2023.

Pune, India - April 9, 2019 /MarketersMedia/ —

ReportsnReports always aims at offering their clients an in-depth analysis and the best research material of the various market. This report on the global genotyping assay market is committed fulfilling the requirements of the clients by giving them thorough insights into the market. An exclusive data offered in this report is collected by research and industry experts team.

The Genotyping Assay Market is expected to reach US$ 31.9 Billion by 2023 from an estimated US$ 11.8 Billion in 2018, at a CAGR of 22.0%. Technological advancements, the decreasing prices of DNA sequencing, and the increasing incidence of genetic diseases are expected to drive the growth of the global genotyping market.
Download Here Free Sample Report of Genotyping Assay Market at https://www.reportsnreports.com/contacts/requestsample.aspx?name=399299

Top Companies in the “Genotyping Assay Market” include are
• Thermo Fisher Scientific (US)
• Illumina (US)
• QIAGEN (Netherlands)
• Agilent Technologies (US)
• Danaher Corporation (US)
• Roche Diagnostics (Switzerland)
• GE Healthcare (US)
• Fluidigm Corporation (US)
• PerkinElmer (US)
• Eurofins Scientific (Luxembourg)
• Bio-Rad Laboratories (US)
• Pacific Biosciences of California (US)
• GENEWIZ (US)
• Integrated DNA Technologies (US)

Browse 219 Tables, 53 Figures, 14 Companies, spread across 280 pages available at https://www.reportsnreports.com/purchase.aspx?name=399299

“Pharmacogenomics application segment to witness the highest growth during the forecast period.”
On the basis of application, the genotyping market is segmented into pharmacogenomics, diagnostic& personalized medicine, agricultural biotechnology, animal genetics, and other applications. The pharmacogenomics segment is expected to register the highest CAGR during the forecast period. The increased use of genotyping to predict the efficiency of drugs during drug development and the growing need to understand the adverse effects of drugs are the major factors driving the growth of this market segment.

“Pharmaceutical and biopharmaceutical companies end-user segment is expected to grow at the highest CAGR during the forecast period.”
On the basis of end user, the Genotyping Market is segmented into pharmaceutical & biopharmaceutical companies, diagnostic & research institutes, academic institutes, and other end users. The pharmaceutical & biopharmaceutical companies segment is expected to witness the highest CAGR owing to the growing importance of biomarkers in genotyping used among these end users, given their applications in drug development which, in turn, will support the growth of this segment.

“APAC is projected to witness the highest growth during the forecast period.”
North America is expected to account for the largest share of the global genotyping market in 2018. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period, owing to the increasing incidence of chronic diseases and growing awareness on the use of genotyping tests to control the inheritance of genetic diseases &the spread of infectious and microbial diseases in APAC countries.

Report Highlights:
• To strategically profile the key players in this market and comprehensively analyze their market shares and core competencies
• To define, describe, and forecast the genotyping market, by product, technology, application, end user, and region
• To provide detailed information regarding factors influencing market growth (such as drivers, restraints, opportunities, challenges, and industry trends)
• To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
• To track and analyze competitive developments such as mergers and acquisitions, product developments and approvals, agreements, collaborations, partnerships, expansions, and funding activities in the genotyping market
• To strategically analyze different geographical regions such as North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa

Ask Discount @ https://www.reportsnreports.com/contacts/discount.aspx?name=399299

Reasons to Buy this Report:
Genotyping Assay Market report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their market presence.

Contact Info:
Name: Snehal Shete
Email: Send Email
Organization: ReportsandReports
Address: Tower B5, Office 101, Magarpatta City SEZ, Pune-411013, India
Phone: +1 888 391 5441
Website: https://www.reportsnreports.com/reports/399299-genotyping-market-by-technology-polymerase-chain-reaction-sequencing-microarray-electrophoresis-malditof-application-pharmacogenomics-diagnostic-research-animal-genetics-agricultural-biotechnology-by-products-global-forecast-to-2020.html

Source URL: https://marketersmedia.com/genotyping-assay-market-to-2023-growing-steady-at-220-cagr-and-projected-to-reach-us-319-billion/500515

Source: MarketersMedia

Release ID: 500515